Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Hydration Pharmaceuticals Co Ltd

HPC.AX ✓ COMPLIANTFree checks used up today ☆ Track — members

ASX · Healthcare · Pharmaceuticals ·

Australia Micro Cap Analyst: N/A

Last Close

$0.00

▲ +0.00%

Market Cap $1.14M · Vol 80.00K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$1.14M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

2.07

vs Market

52W High

$0.01

82.91% below

52W Low

$0.00

0.49% above

Volume

80.00K

Avg 71.46K

P/B

1.01

Price-to-book

ROE

N/A

Return on equity

Free Float

44.42%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Hydration Pharmaceuticals Co Ltd (HPC.AX) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does HPC.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-40.00%

-25.00%

YTD

-40.00%

-70.00%

-91.88%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$2.47M
Net Income	$-2,751,280.00
Revenue Growth (YoY)	-21.14%
Gross Margin	55.18%
Operating Margin	-126.42%
Net Profit Margin	-111.31%
ROE	N/A
ROA · ROIC	-76.54% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.52
P/B	1.01
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	537.99M

Technical Indicators

50-Day SMA	$0.00
200-Day SMA	$0.00
RSI (14)	50.00
Beta	2.07
52-Week High	$0.01
52-Week Low	$0.00

Volume Today	80.00K
Avg Daily Volume (30D)	71.46K
Relative Volume	1.12x
Volatility (10D)	0.00
Volatility (30D)	122.33
Free Float	44.42%

Analyst Consensus

N/A

Current Price $0.00

Mean Target N/A

52W Low$0.00 52W High$0.01

Current

Target

$0.00 $0.01

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG013HLW0F5

ISINAU0000187957

CountryAustralia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Company +1.28% JNJ Johnson & Johnson +1.10% ABBV AbbVie Inc. +0.58% NVS Novartis AG +1.60% NOVN.S Novartis AG +1.52%

Company Profile

The Hydration Pharmaceuticals Company Limited is an Australia-based hydration solutions company. The Company is focused on the sale and distribution of Hydralyte, which includes a product range of electrolyte-rich tablets, liquids, and powders. The Company markets and sells a range of liquid, tablet, and powder healthy hydration solutions products in the North American markets of Canada and the United States, under the Hydralyte brand. The Company operates as a wholesale supplier and online retailer of Hydralyte products in North America. The Company has a sales footprint in various markets, including the United States, Canada, Australia, New Zealand, Asia (excluding China, which includes Hong Kong but excludes Taiwan), Africa and the Middle East (excluding Turkey). Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, and others.